"Hypoxic ischemic brain injury (HIBI)" · 2 results · Global ETD Search

Results

Showing 1 to 2 of 2 for “"Hypoxic ischemic brain injury (HIBI)"”.

Mechanisms of Erythropoietin-induced Neuroprotection in: in-vivo and in-vitro Models of hypoxia Ischema

Souvenir, Rhonda Andrea

Hypoxic ischemic brain injury (HIBI) is a common cause of neonatal mortality and morbidity. Approximately 60 % of preterm babies and 2% of full term infants suffer from asphyxia. Asphyxia related death accounts for approximately 23% of neonatal mortality annually. Many therapeutic interventions …

loma-linda Repository record for Mechanisms of Erythropoietin-induced Neuroprotection in: in-vivo and in-vitro Models of hypoxia Ischema (opens in a new tab)
Pharmacophore-directed retrosynthesis (PDR) and Density functional theory studies applied to the potent ion channel inhibitor waixenicin A : synthetic studies toward a more stable salarin C congener, thia-salarin C, through the lens of PDR.

Parris, Matthew Ray, 1997-Baylor University.2026

Waixenicin A (WaixA) exhibits potent (615 ± 121 nM) and highly selective inhibition of transient receptor melastatin 7 (TRPM7) over closely related ion channels. Thus, WaixA serves as a potential drug lead for the treatment of hypoxic-ischemic brain injury (HIBI) and a compelling target for …

baylor Repository record for Pharmacophore-directed retrosynthesis (PDR) and Density functional theory studies applied to the potent ion channel inhibitor waixenicin A : synthetic studies toward a more stable salarin C congener, thia-salarin C, through the lens of PDR. (opens in a new tab)